← Open Payments lookup

REINALD REVILLA: Open Payments

NPI 1821507716 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,049 in 35 payments from 9 companies in 2025. Trend: 2023 $164 · 2024 $526 · 2025 $1,049

Food & beverage: $1,049
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$258
Janssen Pharmaceuticals, Inc4$235
ABBVIE INC.8$176
E.R. Squibb & Sons, L.L.C.3$146
Neos Therapeutics, LP4$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$69
Takeda Pharmaceuticals U.S.A., Inc.2$39
Supernus Pharmaceuticals, Inc.1$26
Collegium Pharmaceutical, Inc.1$18

Products named: REXULTI, INVEGA SUSTENNA, VRAYLAR, COBENFY, Adzenys XR-ODT, CAPLYTA, TRINTELLIX, SPRAVATO.

Industry payments across CA — which companies pay providers there.